Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleSystemic Lupus Erythematosus

Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort

Manuel F. Ugarte-Gil, Daniel Wojdyla, Guillermo J. Pons-Estel, Rosana Quintana, José A. Gómez-Puerta, Luis J. Catoggio, Alejandro Alvarellos, Verónica Saurit, Eduardo Borba, Emilia Sato, Lilian Costallat, Nilzio A. Da Silva, Antonio Iglesias-Gamarra, Oscar Neira, Gil Reyes-Llerena, Mario H. Cardiel, Mary Carmen Amigo, Eduardo Acevedo-Vásquez, María H. Esteva-Spinetti, Graciela S. Alarcón and Bernardo A. Pons-Estel
The Journal of Rheumatology October 2019, 46 (10) 1299-1308; DOI: https://doi.org/10.3899/jrheum.180433
Manuel F. Ugarte-Gil
From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Sanatorio Parque, Rosario, Santa Fe, Argentina; Servicio de Reumatología, Hospital Clinic, Barcelona, Spain; Sección de Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Instituto Universitario, Escuela de Medicina Hospital Italiano and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires; Servicio de Reumatología, Hospital Privado, Centro Medico de Córdoba, Córdoba, Argentina; Rheumatology Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo; Disciplina de Reumatologia, Escola Paulista de Medicina/UNIFESP, Hospital São Paulo, Universidade Federal de São Paulo, São Paulo; Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas; Faculdade de Medicina, Universidade Federal de Goiás, Goiânia, Brazil; Clínica Saludcoop 104 Jorge Piñeros Corpas and Hospital San Juan de Dios, Universidad Nacional de Colombia, Bogotá, Colombia; Hospital del Salvador, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Servicio de Reumatología, Centro de Investigaciones Médico Quirúrgicas-CIMEQ, Havana, Cuba; Centro de Investigación Clínica de Morelia SC, Morelia, Michoacán; Reumatología, Centro Médico ABC, Ciudad de México, México; Universidad Nacional Mayor de San Marcos, Lima, Peru; Hospital Central de San Cristóbal, San Cristóbal, Venezuela; Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Manuel F. Ugarte-Gil
  • For correspondence: manuel_ugarte@yahoo.com
Daniel Wojdyla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillermo J. Pons-Estel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosana Quintana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José A. Gómez-Puerta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luis J. Catoggio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alejandro Alvarellos
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Verónica Saurit
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Borba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emilia Sato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lilian Costallat
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilzio A. Da Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Iglesias-Gamarra
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oscar Neira
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gil Reyes-Llerena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario H. Cardiel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Carmen Amigo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo Acevedo-Vásquez
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
María H. Esteva-Spinetti
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graciela S. Alarcón
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernardo A. Pons-Estel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 46 no. 10 1299-1308
DOI 
https://doi.org/10.3899/jrheum.180433
PubMed 
30824636

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication December 18, 2018
  • Published online October 1, 2019.

Article Versions

  • Latest version (March 1, 2019 - 04:00).
  • Latest version (June 1, 2019 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019

Author Information

  1. Manuel F. Ugarte-Gil⇑,
  2. Daniel Wojdyla,
  3. Guillermo J. Pons-Estel,
  4. Rosana Quintana,
  5. José A. Gómez-Puerta,
  6. Luis J. Catoggio,
  7. Alejandro Alvarellos,
  8. Verónica Saurit,
  9. Eduardo Borba,
  10. Emilia Sato,
  11. Lilian Costallat,
  12. Nilzio A. Da Silva,
  13. Antonio Iglesias-Gamarra,
  14. Oscar Neira,
  15. Gil Reyes-Llerena,
  16. Mario H. Cardiel,
  17. Mary Carmen Amigo,
  18. Eduardo Acevedo-Vásquez,
  19. María H. Esteva-Spinetti,
  20. Graciela S. Alarcón and
  21. Bernardo A. Pons-Estel
  1. From the Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, EsSalud; Universidad Científica del Sur, Lima, Peru; Grupo Latino Americano De Estudio de Lupus (GLADEL), Rosario, Argentina; Department of Autoimmune Diseases, Hospital Clinic, Barcelona, Spain; Centro Regional de Enfermedades Autoinmunes y Reumáticas (CREAR), Grupo Oroño, Sanatorio Parque, Rosario, Santa Fe, Argentina; Servicio de Reumatología, Hospital Clinic, Barcelona, Spain; Sección de Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Instituto Universitario, Escuela de Medicina Hospital Italiano and Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología, Buenos Aires; Servicio de Reumatología, Hospital Privado, Centro Medico de Córdoba, Córdoba, Argentina; Rheumatology Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo; Disciplina de Reumatologia, Escola Paulista de Medicina/UNIFESP, Hospital São Paulo, Universidade Federal de São Paulo, São Paulo; Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas; Faculdade de Medicina, Universidade Federal de Goiás, Goiânia, Brazil; Clínica Saludcoop 104 Jorge Piñeros Corpas and Hospital San Juan de Dios, Universidad Nacional de Colombia, Bogotá, Colombia; Hospital del Salvador, Facultad de Medicina, Universidad de Chile, Santiago, Chile; Servicio de Reumatología, Centro de Investigaciones Médico Quirúrgicas-CIMEQ, Havana, Cuba; Centro de Investigación Clínica de Morelia SC, Morelia, Michoacán; Reumatología, Centro Médico ABC, Ciudad de México, México; Universidad Nacional Mayor de San Marcos, Lima, Peru; Hospital Central de San Cristóbal, San Cristóbal, Venezuela; Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  2. M.F. Ugarte-Gil, MD, MSc, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur; D. Wojdyla, MSc, GLADEL Consultant; G.J. Pons-Estel, MD, PhD, Department of Autoimmune Diseases, Hospital Clinic, and CREAR, Grupo Oroño; R. Quintana, MD, PhD, CREAR, Grupo Oroño; J.A. Gómez-Puerta, MD, MPH, PhD, Servicio de Reumatología, Hospital Clinic; L.J. Catoggio, MD, PhD, Sección de Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Instituto Universitario, Escuela de Medicina Hospital Italiano, Fundación Dr. Pedro M. Catoggio para el Progreso de la Reumatología; A. Alvarellos, MD, Servicio de Reumatología, Hospital Privado, Centro Medico de Córdoba; V. Saurit, MD, Servicio de Reumatología, Hospital Privado, Centro Medico de Córdoba; E. Borba, MD, Rheumatology Division, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo; E. Sato, MD, PhD, Disciplina de Reumatologia, Escola Paulista de Medicina/UNIFESP, Hospital São Paulo, Universidade Federal de São Paulo; L. Costallat, MD, Faculdade de Ciências Médicas, Universidade Estadual de Campinas; N.A. Da Silva, MD, Faculdade de Medicina, Universidade Federal de Goiás; A. Iglesias-Gamarra, MD, Clínica Saludcoop 104 Jorge Piñeros Corpas and Hospital San Juan de Dios, Universidad Nacional de Colombia; O. Neira, MD, Hospital del Salvador, Facultad de Medicina, Universidad de Chile; G. Reyes-Llerena, MD, Servicio de Reumatología, Centro de Investigaciones Médico Quirúrgicas-CIMEQ; M.H. Cardiel, MD, MSc, Centro de Investigación Clínica de Morelia SC; M.C. Amigo, MD, Reumatología, Centro Médico ABC; E. Acevedo-Vásquez, MD, Department of Rheumatology, Hospital Guillermo Almenara Irigoyen, Universidad Científica del Sur, Universidad Nacional Mayor de San Marcos; M.H. Esteva-Spinetti, MD, Hospital Central de San Cristóbal; G.S. Alarcón, MD, MPH, Department of Medicine, Division of Clinical Immunology and Rheumatology, School of Medicine, University of Alabama at Birmingham; B.A. Pons-Estel, MD, CREAR, Grupo Oroño.
  1. Address correspondence to Dr. M.F. Ugarte-Gil, Rheumatology Department, Hospital Guillermo Almenara Irigoyen, EsSalud, Av. Grau 800, La Victoria, Lima 13, Peru. E-mail: manuel_ugarte{at}yahoo.com

Article usage

Article usage: February 2019 to April 2022

AbstractFullPdf
Feb 2019101
Mar 2019594029
Apr 201911308
May 20198309
Jun 2019146010
Jul 201910604
Aug 20195606
Sep 20196833
Oct 20198244740
Nov 2019343810
Dec 20194671311
Jan 202044254
Feb 20208043
Mar 20207001
Apr 202085610
May 20207824
Jun 20206625
Jul 20203516
Aug 20204613
Sep 20204022
Oct 202063419
Nov 2020142716
Dec 2020242410
Jan 202151613
Feb 2021363324
Mar 2021103017
Apr 2021152911
May 2021884910
Jun 2021293418
Jul 202162914
Aug 2021183922
Sep 2021153425
Oct 2021135118
Nov 202172116
Dec 202174120
Jan 20228239
Feb 202212158
Mar 2022733116
Apr 2022192616

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 46, Issue 10
1 Oct 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort
Manuel F. Ugarte-Gil, Daniel Wojdyla, Guillermo J. Pons-Estel, Rosana Quintana, José A. Gómez-Puerta, Luis J. Catoggio, Alejandro Alvarellos, Verónica Saurit, Eduardo Borba, Emilia Sato, Lilian Costallat, Nilzio A. Da Silva, Antonio Iglesias-Gamarra, Oscar Neira, Gil Reyes-Llerena, Mario H. Cardiel, Mary Carmen Amigo, Eduardo Acevedo-Vásquez, María H. Esteva-Spinetti, Graciela S. Alarcón, Bernardo A. Pons-Estel
The Journal of Rheumatology Oct 2019, 46 (10) 1299-1308; DOI: 10.3899/jrheum.180433

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Predictors of Remission and Low Disease Activity State in Systemic Lupus Erythematosus: Data from a Multiethnic, Multinational Latin American Cohort
Manuel F. Ugarte-Gil, Daniel Wojdyla, Guillermo J. Pons-Estel, Rosana Quintana, José A. Gómez-Puerta, Luis J. Catoggio, Alejandro Alvarellos, Verónica Saurit, Eduardo Borba, Emilia Sato, Lilian Costallat, Nilzio A. Da Silva, Antonio Iglesias-Gamarra, Oscar Neira, Gil Reyes-Llerena, Mario H. Cardiel, Mary Carmen Amigo, Eduardo Acevedo-Vásquez, María H. Esteva-Spinetti, Graciela S. Alarcón, Bernardo A. Pons-Estel
The Journal of Rheumatology Oct 2019, 46 (10) 1299-1308; DOI: 10.3899/jrheum.180433
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ONLINE SUPPLEMENT
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Supplemental
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

SYSTEMIC LUPUS ERYTHEMATOSUS
REMISSION
LOW DISEASE ACTIVITY STATE
RISK FACTORS

Related Articles

Cited By...

More in this TOC Section

  • Gestational Diabetes Mellitus Risk in Pregnant Women With Systemic Lupus Erythematosus
  • High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis
  • Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study
Show more Systemic Lupus Erythematosus

Similar Articles

Keywords

  • systemic lupus erythematosus
  • remission
  • LOW DISEASE ACTIVITY STATE
  • risk factors

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire